Fair Isaac Corporation FICO
712.00 USD -12.38 (-1.71%)
Nov 4, 2026, 3:24 PM EST
700.49 Day range 760.65
592.47 52-week range 1,844.98
- YTD
- -57.89%
- 1 year
- -55.67%
Analyst view
Consensus: buy
Buy
Price target (mean) 897.05 +26.0% upside
Now 712.00
- Target (low)
- 490.00
- Target (mean)
- 897.05
- Target (high)
- 1,230.97
Ratings (0m) 21 10 buy · 9 hold · 2 sell
- Strong buy4
- Buy6
- Hold9
- Sell2
- Strong sell0
Recommendation trend
- This month 21
- 1 month ago 21
- 2 months ago 21
- 3 months ago 21
Earnings and revenue estimates
Consensus for the coming quarters and fiscal years
| Period | EPS estimate | Low – high | Year ago | EPS growth | Revenue estimate | Revenue growth | Analysts |
|---|---|---|---|---|---|---|---|
| Current quarter | 10.71 | 10.15 – 11.25 | 7.74 | +38.4% | 651.31M | +26.3% | 17 |
| Next quarter | 9.78 | 7.49 – 11.15 | 7.33 | +33.5% | 613.64M | +19.9% | 17 |
| Current year | 42.66 | 42.09 – 43.55 | 29.88 | +42.8% | 2.53B | +27.0% | 21 |
| Next year | 46.28 | 32.33 – 53.04 | 42.66 | +8.5% | 2.66B | +5.1% | 21 |
Upgrades and downgrades
The latest rating changes
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| Nov 2, 2026 | Jefferies | Maintained | Buy | Buy |
| Oct 26, 2026 | UBS | Maintained | Neutral | Neutral |
| Oct 26, 2026 | BMO Capital | Maintained | Outperform | Outperform |
| Oct 26, 2026 | JP Morgan | Maintained | Neutral | Neutral |
| Oct 26, 2026 | Wells Fargo | Downgrade | Overweight | Equal-Weight |
| Oct 19, 2026 | Mizuho | Maintained | Outperform | Outperform |
| Oct 16, 2026 | RBC Capital | Maintained | Outperform | Outperform |
| Oct 13, 2026 | Raymond James | Maintained | Outperform | Outperform |
| Oct 13, 2026 | Needham | Maintained | Buy | Buy |
| Oct 5, 2026 | Wells Fargo | Maintained | Overweight | Overweight |
| Oct 2, 2026 | Barclays | Maintained | Overweight | Overweight |
| Oct 2, 2026 | Baird | Maintained | Outperform | Outperform |
| Sep 30, 2026 | B of A Securities | Downgrade | Buy | Neutral |
| Sep 30, 2026 | BMO Capital | Maintained | Outperform | Outperform |
| Sep 30, 2026 | Barclays | Maintained | Overweight | Overweight |
| Sep 30, 2026 | Wells Fargo | Maintained | Overweight | Overweight |
| Sep 22, 2026 | Wells Fargo | Maintained | Overweight | Overweight |
| Aug 12, 2026 | UBS | Maintained | Neutral | Neutral |
| Aug 10, 2026 | Barclays | Maintained | Overweight | Overweight |
| Aug 3, 2026 | Wolfe Research | Downgrade | Outperform | Peer Perform |
| Jul 30, 2026 | RBC Capital | Maintained | Outperform | Outperform |
| Jul 30, 2026 | Wells Fargo | Maintained | Overweight | Overweight |
| Jul 30, 2026 | Needham | Reiterated | Buy | Buy |
| Jul 2, 2026 | UBS | Maintained | Neutral | Neutral |
| Jun 16, 2026 | UBS | Maintained | Neutral | Neutral |
| Jun 9, 2026 | Needham | Reiterated | Buy | Buy |
| May 19, 2026 | B of A Securities | Maintained | Buy | Buy |
| May 4, 2026 | Jefferies | Maintained | Buy | Buy |
| Apr 30, 2026 | JP Morgan | Maintained | Neutral | Neutral |
| Apr 30, 2026 | Wells Fargo | Maintained | Overweight | Overweight |
